Literature DB >> 17145743

Thiazolidinediones for initial treatment of type 2 diabetes?

David M Nathan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17145743     DOI: 10.1056/NEJMe068264

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  9 in total

1.  The fate of Beta-cells in type 2 diabetes and the possible role of pharmacological interventions.

Authors:  Baptist Gallwitz
Journal:  Rev Diabet Stud       Date:  2007-02-10

2.  Safety and Efficacy of D-Tagatose in Glycemic Control in Subjects with Type 2 Diabetes.

Authors:  Mark Ensor; Amy B Banfield; Rebecca R Smith; Jarrod Williams; Robert A Lodder
Journal:  J Endocrinol Diabetes Obes       Date:  2014-12-31

3.  Effects of Three Low-Doses of D-Tagatose on Glycemic Control Over Six Months in Subjects with Mild Type 2 Diabetes Mellitus Under Control with Diet and Exercise.

Authors:  Mark Ensor; Jarrod Williams; Rebecca Smith; Amy Banfield; Robert A Lodder
Journal:  J Endocrinol Diabetes Obes       Date:  2014-10

4.  Thiazolidinediones and bone.

Authors:  Alberto Falchetti; Laura Masi; Maria Luisa Brandia
Journal:  Clin Cases Miner Bone Metab       Date:  2007-05

5.  Impact of pioglitazone on coronary endothelial function in non-diabetic patients with coronary artery disease.

Authors:  Jochen Wöhrle; Nikolaus Marx; Wolfgang Koenig; Vinzenz Hombach; Hans A Kestler; Martin Höher; Thorsten Nusser
Journal:  Clin Res Cardiol       Date:  2008-04-24       Impact factor: 5.460

6.  [Metformin also as first choice in patients with normal weight. Has its use increased?].

Authors:  Eduardo Carracedo-Martínez; Agustin Pia-Morandeira
Journal:  Aten Primaria       Date:  2009-05-21       Impact factor: 1.137

Review 7.  Effect of non-oil-seed pulses on glycaemic control: a systematic review and meta-analysis of randomised controlled experimental trials in people with and without diabetes.

Authors:  J L Sievenpiper; C W C Kendall; A Esfahani; J M W Wong; A J Carleton; H Y Jiang; R P Bazinet; E Vidgen; D J A Jenkins
Journal:  Diabetologia       Date:  2009-06-13       Impact factor: 10.122

8.  Durability of initial antidiabetic monotherapy and subsequent treatment adjustment patterns among newly treated type 2 diabetes patients.

Authors:  Yoojin Noh; Sukhyang Lee; Sooyoung Shin
Journal:  Ther Clin Risk Manag       Date:  2018-09-03       Impact factor: 2.423

9.  Design of glucagon-like Peptide-1 receptor agonist for diabetes mellitus from traditional chinese medicine.

Authors:  Hsin-Chieh Tang; Calvin Yu-Chian Chen
Journal:  Evid Based Complement Alternat Med       Date:  2014-05-06       Impact factor: 2.629

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.